Distribution Policies of Insulinic Consumptions and Medicines in the Single Health System

Diabetes mellitus is a chronic pathology that evolves slowly and presents different complications. The predisposition to the development of diabetes mellitus involves genetic factors and/or comorbidities, and can be classified as diabetes mellitus TYPE 1 (autoimmune), TYPE 2 (metabolic), among others. The general objective of this research is to understand the factors associated with the organization of insulin input management in public health distribution . The present study is a qualitative literature review, using scientific articles published in the SciELO, VHL (Virtual Health Library) and PubMed databases . It was observed, from reading the articles, that DM is one of the most relevant chronic morbidities in Brazil, with its impact associated with the large number of people affected. Between 2017 and 2021, 649,337 new cases of diabetes mellitus were diagnosed in the country. The present study highlighted the importance of discussing public policies aimed at DM in Brazil in an emerging way, considering that some actions for the distribution of inputs and medicines have already been developed, but have not been carried out effectively.